Skip to main content

Spastic Paraplegia 75

OMIM ID:

autosomal recessive

Spastic Paraplegia 75

Alternate Names

SPG75

Defective Genes

MAG

Clinical Characteristics

Ocular Features

Nystagmus with optic atrophy is usually present and one individual had glaucoma. 

Systemic Features

This is an early-onset and progressive neurodegenerative disorder.  Hypotonia may be present at birth.  A spastic gait and difficulty walking is noted in early childhood and most individuals never walk unassisted. Yong adults have spastic paresis with extensor plantar responses and clonus has been reported.  Distal muscle atrophy in the lower extremities has been noted.  Speech is dysarthric.  Brain imaging has been normal in some patients whereas others have mild atrophy of the cerebellum and the corpus callosum.  Cognitive impairment is variable with some individuals showing poor school performance while others are described as mentally retarded.

Genetics

Inheritance

Homozygous mutations in the MAG gene (19q13.12) are responsible for this disorder.

Pedigree

Autosomal recessive

In order for autosomal recessive disorders to be expressed, offspring generally must inherit two mutations, one from each carrier parent.  Carriers with only one mutation, such as the parents, do not have clinical disease.  Note that carrier parents can expect that 1 in 4 children (25%) will inherit both mutations and have the disorder, 2 in 4 children (50%) will be carriers like their parents, while 1 in 4 children (25%) inherit neither mutation.

Image
Sample pedigree of autosomal recessive inheritance

In order for autosomal recessive disorders to be expressed, offspring generally must inherit two mutations, one from each carrier parent. Carriers with only one mutation, such as the parents, do not have clinical disease. Note that carrier parents can expect that 1 in 4 children (25%) will inherit both mutations and have the disorder, 2 in 4 children (50%) will be carriers like their parents, while 1 in 4 children (25%) inherit neither mutation.

Treatment & Management

No effective treatment has been reported although physical therapy may be helpful. Special education, speech and physical therapy, and low vision devices might also be of benefit.

Selected Resources

Publications

Displaying 1 - 2 of 2

Exome Sequencing Links Corticospinal Motor Neuron Disease to Common Neurodegenerative Disorders

PubMedID: 24482476

Myelin-associated glycoprotein gene mutation causes Pelizaeus-Merzbacher disease-like disorder

PubMedID: 26179919